Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DNLI | OUST |
|---|---|---|
| Price | $19.91 | $44.12 |
| Change today | ▼ 0.45% | ▼ 0.61% |
| Market cap | $3.18B | $3.18B |
| Return, 3 months | -24.3% | +0.1% |
| Return, year to date | +20.6% | +103.9% |
| Return, 1 year | +30.8% | +36.0% |
| P/E (TTM) | -7.0 | -53.2 |
| P/B | 3.8 | 8.6 |
| P/E percentile vs own 5y | 68th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +76.2% | +38.8% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 36 | 62 |
| 30-day volatility | 35.6% | 65.1% |
| Max drawdown, 1 year | -27.5% | -55.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
